Suppr超能文献

一种新的飞秒激光辅助角膜弓形切开术的列线图的精确性和屈光预测性。

Precision and refractive predictability of a new nomogram for femtosecond laser-assisted corneal arcuate incisions.

机构信息

Department of Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Linz, Austria.

Augen-und Laserklinik, Castrop-Rauxel, Germany.

出版信息

Acta Ophthalmol. 2021 Dec;99(8):e1297-e1306. doi: 10.1111/aos.14837. Epub 2021 Feb 24.

Abstract

PURPOSE

Validating a new nomogram for low to moderate astigmatism (0.75 D to 2.5 D) correction with epithelium- and Bowman-penetrating femtosecond laser-assisted arcuate incisions.

METHODOLOGY

Prospective, interventional case series at the Augen- und Laserklinik, Castrop-Rauxel, Germany. Cataract patients with low to moderate corneal astigmatism were treated with femtosecond laser-assisted arcuate incisions. Patients with previous refractive corneal treatment were excluded. Outcome assessment was based on manifest refraction, astigmatic vector analysis and visual acuity.

RESULTS

The study analysed 43 eyes of 33 patients after three months and 35 eyes of 27 patients after 12 months. After 12 months, 100% of all eyes treated had ≤1.0 D and 97% ≤0.5 D of subjective residual astigmatism. Mean residual astigmatism was 0.27 D. 90% of all eyes were within one line of difference between UDVA and CDVA. SEQ Mean Absolute Error was 0.26 D and SEQ. Mean error was -0.08 ± 0.32 D. CI was 0.98 ± 0.2 D, and Index of Success, 0.20 ± 0.18 D.

CONCLUSION

The Castrop nomogram showed results that are comparable to or better than results presented in the literature for existing nomograms. Our results for astigmatic reduction are comparable to published results for TIOL implantation. It seems to be a predictable and safe measure to reduce manifest astigmatism.

摘要

目的

验证一种新的用于矫正低中度散光(0.75D 至 2.5D)的上皮和Bowman 穿透飞秒激光辅助弧形切口的列线图。

方法

前瞻性、干预性病例系列研究,在德国卡斯特罗普-劳克塞尔的 Augen- und Laserklinik 进行。对伴有低中度角膜散光的白内障患者进行飞秒激光辅助弧形切口治疗。排除有既往屈光性角膜治疗史的患者。疗效评估基于主观验光、散光矢量分析和视力。

结果

本研究在术后 3 个月分析了 33 名患者的 43 只眼,术后 12 个月分析了 27 名患者的 35 只眼。术后 12 个月,所有治疗眼的 100%有≤1.0D 和 97%≤0.5D 的主观剩余散光。平均剩余散光为 0.27D。90%的眼在 UDVA 和 CDVA 之间的差异在一行内。SEQ 平均绝对误差为 0.26D,SEQ 平均误差为-0.08±0.32D。CI 为 0.98±0.2D,成功率指数为 0.20±0.18D。

结论

卡斯特罗普列线图的结果与现有列线图的结果相当或更好。我们的散光矫正结果与已发表的 TIOL 植入结果相当。这似乎是一种可预测且安全的降低角膜散光的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50cd/9540120/9b15379dfe6d/AOS-99-e1297-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验